Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity

Jacqueline Ramírez, Wanqing Liu, Snezana Mirkov, Apurva A. Desai, Peixian Chen, Soma Das, Federico Innocenti and Mark J. Ratain
Drug Metabolism and Disposition December 2007, 35 (12) 2149-2153; DOI: https://doi.org/10.1124/dmd.107.015446
Jacqueline Ramírez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanqing Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Snezana Mirkov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apurva A. Desai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peixian Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soma Das
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Federico Innocenti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Ratain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Interindividual variability in the glucuronidation of xenobiotics metabolized by UDP-glucuronosyltransferase 1A9 (UGT1A9) suggests the presence of functional UGT1A9 variants. The aim of this study was to evaluate whether the putative functionality of the UGT1A9 variants–118T9>10 (rs3832043), I399C>T (rs2741049), –275T>A (rs6714486), and–2152C>T (rs17868320) could be confirmed in an independent study. UGT1A9 genotypes and UGT1A9 activity (i.e., flavopiridol and mycophenolic acid glucuronidation) were determined in 46 Caucasian human livers. mRNA levels were quantitated by real-time polymerase chain reaction in 35 of these livers. In addition, samples from 60 unrelated Caucasians belonging to the HapMap Project were also genotyped to confirm the allele frequencies and linkage disequilibrium (LD) pattern observed in our Caucasian livers. The allele frequencies of the–118T9>10, I399C>T, –275T>A, and–2152C>T variants were 0.39, 0.39, 0.02, and 0.02 in the livers, respectively. The I399C>T variant was in complete LD (r2 = 1) with–118T9>10 (linked alleles: C and T9, respectively). Complete LD between these two variants was also found in the HapMap samples (frequencies of–118T9>10 and I399C>T = 0.38). I399C>T and–118T9>10 correlated with neither UGT1A9 activities nor mRNA levels. Because of the low frequencies of the–275T>A and–2152C>T variants, an effect on phenotype could not be evaluated. Our data demonstrate that the common I399C>T and–118T9>10 polymorphisms do not explain interindividual variation in hepatic UGT1A9 activity and mRNA expression and are in complete LD in the donor liver samples we studied.

Footnotes

  • This work was supported by the Pharmacogenetics of Anticancer Agents Research Group (http://pharmacogenetics.org) [National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) Grant U01GM61393]. Data will be deposited into PharmGKB (supported by NIH/NIGMS U01GM61374, http://pharmgkb.org/).

  • J.R. and W.L. contributed equally to this work.

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.107.015446.

  • ABBREVIATIONS: UGT, uridine diphosphate-glucuronosyltransferase; SN-38, 7-ethyl-10-hydroxycamptothecin; SNP, single nucleotide polymorphism; LD, linkage disequilibrium; CEPH, Centre d'Etude du Polymorphisme Humain; PCR, polymerase chain reaction; MPAG, mycophenolic acid phenyl glucuronide; UDPGA, uridine 5′-diphospoglucuronic acid; FLAVO-7-G, flavopiridol-7-glucuronide; bp, base pair(s); KS, Komolgorov-Smirnoff.

    • Received February 27, 2007.
    • Accepted August 29, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 35 (12)
Drug Metabolism and Disposition
Vol. 35, Issue 12
1 Dec 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity

Jacqueline Ramírez, Wanqing Liu, Snezana Mirkov, Apurva A. Desai, Peixian Chen, Soma Das, Federico Innocenti and Mark J. Ratain
Drug Metabolism and Disposition December 1, 2007, 35 (12) 2149-2153; DOI: https://doi.org/10.1124/dmd.107.015446

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Lack of Association between Common Polymorphisms in UGT1A9 and Gene Expression and Activity

Jacqueline Ramírez, Wanqing Liu, Snezana Mirkov, Apurva A. Desai, Peixian Chen, Soma Das, Federico Innocenti and Mark J. Ratain
Drug Metabolism and Disposition December 1, 2007, 35 (12) 2149-2153; DOI: https://doi.org/10.1124/dmd.107.015446
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro P450 Suppression by Peptide Not Observed in Clinic
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics